BMRN vs NRXPW · P/E 40, rev $1.76B vs rev $242.0K
Biomarin Pharmaceutical Inc (BMRN) versus NRx Pharmaceuticals Inc (NRXPW) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. NRXPW currently screens at market cap $714.6M.
Not investment advice. Open the BMRN and NRXPW stock pages for the full models.
Not investment advice.